Noridian Releases FAQs for Devices Under Philips Recall
Documents for DME MAC Jurisdictions A and D provide direction on coverage and billing impacts for devices falling under the Philips PE-PUR foam recall.
- By David Kopf
- Jun 29, 2021
Noridian Healthcare Solutions’ education team has released two FAQ documents for DME MAC Jurisdictions A and D that provide direction on coverage and billing impacts of the Philips recall on Medicare beneficiaries.
The American Association for Homecare reviewed both FAQs and reported they appear to be identical. The two documents are:
The documents offer guidance on 10 main questions, including:
- What should DME suppliers and beneficiaries do if they have devices impacted by the voluntary recall?
What actions should DME suppliers take, based on the recall information?
- How should DME suppliers address the situation with Medicare beneficiaries who are in the first 90-days adherence metric in the PAP and RAD Local Coverage Determinations (LCDs)?
- Once a beneficiary gets the new replacement equipment, do they have to restart the 90-day adherence trial? Or do they just pick it up where they left off?
- What should DME suppliers do if a beneficiary wishes to return their Philips Respironics product that is impacted by the voluntary recall?
David Kopf is the Publisher HME Business, DME Pharmacy and Mobility Management magazines. He was Executive Editor of HME Business and DME Pharmacy from 2008 to 2023. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.